REFRESH RELIEVA- carboxymethylcellulose sodium, glycerin solution/ drops 
Allergan, Inc.

----------

REFRESH RELIEVA®
Drug Facts

Active ingredients

Carboxymethylcellulose sodium 0.5%

Glycerin 0.9%

Purpose

Eye lubricant

Eye lubricant

Uses

Warnings

Stop use and ask a doctor if

you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Instill 1 or 2 drops in the affected eye(s) as needed.

Other information

Inactive ingredients

Boric acid; calcium chloride dihydrate; erythritol; magnesium chloride hexahydrate; potassium chloride; purified water; PURITE® (stabilized oxychloro complex); sodium borate decahydrate; sodium citrate dihydrate; and sodium hyaluronate. May contain hydrochloric acid and/or sodium hydroxide (to adjust pH).

Questions or comments?

1.800.678.1605

refreshbrand.com

v1.0DFL6630

PRINCIPAL DISPLAY PANEL

NDC 0023-6630-10
Refresh®
RELIEVA®
Lubricates and
Protects
0.33 fl oz (10 mL) Sterile

NDC 0023-6630-10
Refresh®
RELIEVA®
Lubricates and 
Protects
0.33 fl oz (10 mL) Sterile

REFRESH RELIEVA 
carboxymethylcellulose sodium, glycerin solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0023-6630
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311) (CARBOXYMETHYLCELLULOSE - UNII:05JZI7B19X) CARBOXYMETHYLCELLULOSE SODIUM5 mg  in 1 mL
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN9 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
BORIC ACID (UNII: R57ZHV85D4)  
CALCIUM CHLORIDE (UNII: M4I0D6VV5M)  
ERYTHRITOL (UNII: RA96B954X6)  
MAGNESIUM CHLORIDE (UNII: 02F3473H9O)  
POTASSIUM CHLORIDE (UNII: 660YQ98I10)  
WATER (UNII: 059QF0KO0R)  
SODIUM CHLORITE (UNII: G538EBV4VF)  
SODIUM BORATE (UNII: 91MBZ8H3QO)  
TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K)  
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
HYDROCHLORIC ACID (UNII: QTT17582CB)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0023-6630-101 in 1 CARTON07/22/2019
110 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
2NDC:0023-6630-031 in 1 CARTON07/22/2019
23 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01807/22/2019
Labeler - Allergan, Inc. (144796497)

Revised: 12/2022
Document Id: 0cdd2598-7802-4f90-ba37-d8eb75d8332b
Set id: 6b984fa2-4187-45ef-b7d3-15e720abc667
Version: 4
Effective Time: 20221208
 
Allergan, Inc.